Ticker
BOLTCompany Name
BOLT BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
6/30/2025 | $ 75.5M | $ 4.17M | 5.52% |
3/31/2025 | $ 85.86M | $ 3.64M | 4.24% |
12/31/2024 | $ 99.63M | $ 7.69M | 7.72% |
9/30/2024 | $ 109.33M | $ 9.78M | 8.94% |
6/30/2024 | $ 124.18M | $ 11.17M | 8.99% |
3/31/2024 | $ 142.89M | $ 11.32M | 7.92% |
12/31/2023 | $ 159.78M | $ 7.88M | 4.93% |
9/30/2023 | $ 175.35M | $ 7.2M | 4.1% |
6/30/2023 | $ 190.7M | $ 6.78M | 3.56% |
3/31/2023 | $ 206.18M | $ 6.74M | 3.27% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for BOLT BIOTHERAPEUTICS INC is calculated as follows: GP [ $ 0 ] / Assets [ $ 61.74M ]
(=) GPA [ 0% ]
Minimum
Sep 30, 2021
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 4.13K |
---|---|
min | -50.32% |
max | 83.98% |
average | 20.16% |
median | 15.35% |
std | 19.94% |